• Academies of Science seeks greater international cooperation
• Nigeria, others can screen more people as WHO lists diagnostics for emergency use
The National Agency for Food, Drug Administration and Control (NAFDAC) has granted conditional emergency use approval of medical devices for COVID-19 antibody, as well as antigen test kits to manufacturing companies and importers of such devices.
It explained that the test kits (IgG/IgM) could be used on COVID-19 confirmed individuals, who could then be tested at designated centres to confirm that they have anti-bodies and as such may not be infected again.
The agency added that the antigen tests kits could also detect the COVID-19 antigen in patients with or without symptoms and that the results could only be positive or negative.
NAFDAC, however, cautioned that no vaccines have been approved for any clinical trial and that it might not happen between a year and 18 months, after clinical trials must have been conducted in different…
Source: Guardian Newspaper
